NCT00377728View on ClinicalTrials.gov

Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

PHASE2CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Rhinitis, Allergic, SeasonalSeasonal Allergic Rhinitis

Interventions

DRUG

GSK256066

Trial Locations (1)

A-1150

GSK Investigational Site, Vienna

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY